Lenacapavir, sold as Sunlenca, has been shown through twice-yearly injections to completely prevent HIV infection in women ...

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

Yearly lenacapavir injection for HIV prevention shows safety and long-lasting effects, according to clinical trial results.

US funding cuts will lead to an additional 2,000 new HIV infections each day and over six million further deaths over the ...

Gilead Sciences has been one of the best-performing large biotech companies over the past year, rising about 50%. That is ...

The CDC budget cuts could pose headwinds for HIV drugmakers like Gilead and Merck but are unlikely to severely cripple their ...

News of potential federal budget cuts impacting HIV drugs in the U.S. was quickly reflected in a dip in share prices for top ...

Winnie Byanyima, head of UNAIDS, criticized the impact of reduced U.S. funding in combatting HIV. She proposed a deal to U.S.